Potent inhibition of scrapie prion replication in cultured cells by bis-acridines.
about
Continuous quinacrine treatment results in the formation of drug-resistant prions2-Aminothiazoles as therapeutic leads for prion diseasesHot spots in prion protein for pathogenic conversionDisease-Associated Polyglutamine Stretches in Monomeric Huntingtin Adopt a Compact StructureSystematic identification of antiprion drugs by high-throughput screening based on scanning for intensely fluorescent targets.New inhibitors of scrapie-associated prion protein formation in a library of 2000 drugs and natural products.Parallel synthesis of 9-aminoacridines and their evaluation against chloroquine-resistant Plasmodium falciparumBis-acridines as lead antiparasitic agents: structure-activity analysis of a discrete compound library in vitro.Efficacy of novel acridine derivatives in the inhibition of hPrP90-231 prion protein fragment toxicity.Chemical induction of misfolded prion protein conformers in cell culture.The concept of privileged structures in rational drug design: focus on acridine and quinoline scaffolds in neurodegenerative and protozoan diseases.Mefloquine, an antimalaria drug with antiprion activity in vitro, lacks activity in vivoQuinacrine treatment trial for sporadic Creutzfeldt-Jakob disease.Protein-misfolding diseases and chaperone-based therapeutic approaches.Antiprion compounds that reduce PrP(Sc) levels in dividing and stationary-phase cells.A survey of antiprion compounds reveals the prevalence of non-PrP molecular targets.Prion diseases: from molecular biology to intervention strategies.Phosphorothioate oligonucleotides reduce PrP levels and prion infectivity in cultured cells.Mechanistic insights into the cure of prion disease by novel antiprion compoundsPotent inhibition of tau fibrillization with a multivalent ligand.An overview of transmissible spongiform encephalopathies.QSAR study of anti-prion activity of 2-aminothiazoles.Tau-based treatment strategies in neurodegenerative diseasesSmall-molecule theranostic probes: a promising future in neurodegenerative diseases.Quinacrine promotes replication and conformational mutation of chronic wasting disease prions.Multitarget ligands and theranostics: sharpening the medicinal chemistry sword against prion diseases.G-quadruplexes within prion mRNA: the missing link in prion disease?Modulation of prion protein oligomerization, aggregation, and beta-sheet conversion by 4,4'-dianilino-1,1'-binaphthyl-5,5'-sulfonate (bis-ANS).Approaches for discovering anti-prion compounds: lessons learned and challenges ahead.Treatment with a non-toxic, self-replicating anti-prion delays or prevents prion disease in vivo.Rational approach to an antiprion compound with a multiple mechanism of action.Exploring Anti-Prion Glyco-Based and Aromatic Scaffolds: A Chemical Strategy for the Quality of Life.Hybrid lipoic acid derivatives to attack prion disease on multiple fronts.The suppression of prion propagation using poly-L-lysine by targeting plasminogen that stimulates prion protein conversion.An acridine derivative, [4,5-bis{(N-carboxy methyl imidazolium)methyl}acridine] dibromide, shows anti-TDP-43 aggregation effect in ALS disease models.Cyclodextrins inhibit replication of scrapie prion protein in cell culture.Tricyclic antidepressants, quinacrine and a novel, synthetic chimera thereof clear prions by destabilizing detergent-resistant membrane compartments.Structure-activity relationship of cyclic thiacarbocyanine tau aggregation inhibitors.Prediction of antiprion activity of therapeutic agents with structure-activity models.[Creutzfeldt-Jakob disease, Heidenhain variant: case report with MRI (DWI) findings].
P2860
Q21090510-CF46E0A6-23FD-404A-A4FE-E08A391C7E96Q24618566-7CE8D4A1-BE94-41DE-8B56-7B37EF9C517DQ24670553-823EC626-7F28-48A2-97FA-A3F9CF51F99EQ27677065-618C6B3C-A65C-48CD-9D1B-17A69CBC482CQ30784753-FC693368-8046-45B9-A6EF-A204FEA68372Q31156724-13E9C930-4102-4A0D-B5CB-009D42FC7C71Q33224951-6C5B65B6-BC98-4B2F-87C4-AFFFF2813A51Q33279371-E5605B05-E754-42D5-B002-11817928996AQ33560026-E65F1332-E794-4E8D-8119-69F09FC03A04Q33796040-E81B4ACA-32EF-4548-850E-3B304A2A27F3Q34286572-4E7DBBAF-E5AF-4B2C-9A7A-F5AA5778DF44Q34301832-C610C476-964A-4E3B-A75F-B40E2CEB7C6BQ34415659-F771F4CE-AAEE-4DDD-AF6E-A5ECA96AE174Q34524526-19A90B7F-6278-4690-8251-8EA8798DC762Q35030768-142CB09D-F2BD-4F8A-BB08-B0DE38D68363Q35145020-EA6E8721-23F1-46C8-A3F4-9AA6E7D04A48Q35602374-6F4EF606-FA4D-4383-994C-832550FB3334Q35844090-57EA35ED-A571-42DD-8A10-2AA5C91E9035Q36099134-95DFF38F-E49A-4279-88B9-A023750502B1Q36103300-2A1FFEDF-CAD6-4722-8842-0F9E3D36BAB5Q36177322-EE573CE7-F392-43FE-A3EA-00BC4A822B52Q37089557-0E538D40-E853-4B31-9A3F-9F88F147A387Q37215861-0A2D045D-725F-4F69-8C50-C053251BFED2Q37353880-CCB475E6-4F03-4EA6-9642-72D63FC35FC2Q37725318-8FC94F9F-9665-4B3C-9BD6-CE58D738D19BQ38234645-AB9E1F80-D1E2-441E-BE3A-DCD93F76786DQ38305734-C581BB4B-7428-46A3-8A18-CE47BB705A5EQ38347673-3EF54E51-04EE-42C0-8F8E-8522EFD8673EQ38356026-AC8E9B3B-2ACC-4122-96A0-2C7C6055B1B1Q38718288-E58C2324-ED2B-40A0-B74F-2CB7F7173A0FQ38948910-83832F7A-B0F6-43FC-8011-0C1FDAE2D235Q39326827-6E810F0C-7DCD-40A4-8B4D-1B3D42E178C2Q39574917-24189E61-B918-475F-97F3-5481DF8AF7B8Q39599032-0F27E7B5-4863-4BBC-919D-8502943224D3Q39612001-ADCCFCFD-34FE-40D8-8BD6-E28023C6546EQ40093984-CB3390A7-74A2-404C-AFD8-F24E7E548A34Q40272134-E2351D96-0912-46B7-99E3-95C447C47ED2Q42060140-3EDC14B1-4442-470E-A8DE-E5FE99ACE2E3Q43966734-324540A9-EC30-4549-B84A-AB25AC55B46AQ44965016-91E6CAE1-C137-43C9-BEE8-B1A8591C07F4
P2860
Potent inhibition of scrapie prion replication in cultured cells by bis-acridines.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Potent inhibition of scrapie prion replication in cultured cells by bis-acridines.
@ast
Potent inhibition of scrapie prion replication in cultured cells by bis-acridines.
@en
type
label
Potent inhibition of scrapie prion replication in cultured cells by bis-acridines.
@ast
Potent inhibition of scrapie prion replication in cultured cells by bis-acridines.
@en
prefLabel
Potent inhibition of scrapie prion replication in cultured cells by bis-acridines.
@ast
Potent inhibition of scrapie prion replication in cultured cells by bis-acridines.
@en
P2093
P2860
P356
P1476
Potent inhibition of scrapie prion replication in cultured cells by bis-acridines.
@en
P2093
Aaron T Fafarman
Barnaby C H May
Leslie W Deady
Michael Rogers
Septima B Hong
P2860
P304
P356
10.1073/PNAS.2627988100
P407
P577
2003-03-07T00:00:00Z